PIA
AGN

Phoenix Investment Adviser’s Allergan plc AGN Stock Holding History

Phoenix Investment Adviser’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-500
Closed -$73K – 48
2019
Q1 		$73K Buy
+500
New +$72.5K 0.16% 32

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Phoenix Investment Adviser's AGN Position: Q2 2019 in Review

Phoenix Investment Adviser sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 500 shares — an estimated $73K sold.

Phoenix Investment Adviser first reported a position in AGN in Q1 2019 and held it in 1 quarter. The position peaked at $73K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Phoenix Investment Adviser reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Phoenix Investment Adviser sold 500 Allergan plc shares in Q2 2019, an estimated $73K.
  • Phoenix Investment Adviser first reported a position in Allergan plc in Q1 2019 and held it in 1 quarter.
  • Phoenix Investment Adviser's Allergan plc position peaked at $73K in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Phoenix Investment Adviser's 13F filing for Q2 2019, filed 12 Aug 2019.